AI biotechs launch bioprospecting expeditions with Indigenous groups, agree to share benefits
By Ben Johnson,
Nature
| 02. 14. 2025
A London-based biotech has amassed the world’s largest ethically sourced foundational biodiversity database for training artificial intelligence (AI) by setting up partnerships with 25 countries around the world. The startup, Basecamp Research, announced in January the launch of a new computer cluster that will mine their rich biodiversity database — which contains species collected from extreme locations such as the Arctic tundra and African deserts — to develop new and unique proteins with commercial potential. In agreeing to share revenues from these proteins before conducting its explorations, Basecamp brings an unusual approach to commercial bioprospecting, an activity traditionally associated with injustices towards Indigenous cultures, biopiracy and colonial practices.
The age-old search for medicines derived from nature has entered a new era. Driven by the need to increase the number of proteins to better train machine-learning algorithms, commercial bioprospecting is undergoing a renaissance. Scientists are going into unexplored areas to sample the genomes and proteins of millions of species with the ultimate goal of finding better versions of what is already in nature.
AI-based design has so far been limited to...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...